3 ms·
Kezar Life Sciences to lay off 70% of workforce as dispute with FDA continues
- WarOnPrivacy 1y agohttps://archive.fo/cHOe2 https://archive.fo/cHOe2
- WarOnPrivacy 1y agofederal regulators canceled a meeting around the company's experimental drug to treat a debilitating liver condition. The delayed meeting with the Food and Drug Administration essentially let loose a domino action: The company's future clinical trial plans are set back and it must find ways to reduce its cash burn in the meantime.